Synthetic DNA vectors and methods of use
AssigneeIntergalactic Therapeutics, Inc.
InventorsBruce C. Schnepp, Philip R. Johnson
Life of this patent
Estimating the term…
Abstract
Provided herein are isolated DNA vectors comprising a heterologous gene, wherein the DNA vector is devoid of bacterial plasmid DNA and/or bacterial signatures, which can abrogate persistence in vivo. The invention also features pharmaceutical compositions (non-immunogenic pharmaceutical compositions) including the DNA vectors of the invention, which can be used for induction of long-term, episomal expression of a heterologous gene in a subject. The invention involves methods of treating a subject by administering the DNA vectors of the invention, including methods of treating disorders associated with a defect in a target gene.
Claims17
A pharmaceutical composition for delivery of a gene in a subject, wherein the pharmaceutical composition comprises a synthetic circular DNA vector comprising a promoter operably linked to the gene, wherein the synthetic circular DNA vector lacks an origin of replication, a drug resistance gene, and a site-specific recombination recognition site, wherein the promoter is capable of inducing expression of the gene in the subject.
Dependencies are inferred from the claim text.